.jpg)
Jarden today confirmed its participation in the launch of the S&P/NZX 20 Index Futures contract on the NZX Equity Derivatives Market — a significant step forward for New Zealand's capital markets and the first active domestic equity futures product in 35 years.
Jarden's Co-CEO, Daniel Reynolds, said: "This is a meaningful development for anyone invested in New Zealand equities. For the first time in 35 years, investors have access to an exchange-traded tool that lets them hedge, gain exposure, and manage risk in the New Zealand market with real precision. We're proud to play a role in making that possible."
As both a Trading and Clearing Participant on the NZX Equity Derivatives Market, Jarden is committed to supporting the development of a liquid and sustainable market for this product, including providing liquidity and offering clients access to the contract through its specialist Listed Derivatives team.
A Long-Awaited Development for New Zealand
The launch of the S&P/NZX 20 Index Futures contract addresses a gap that has existed in New Zealand's capital markets since the early 1990s, when the country's equity futures market was effectively wound down following the sale of the New Zealand Futures and Options Exchange to the Sydney Futures Exchange. Previous efforts to re-establish a domestic index futures market were unable to gain the institutional traction required to sustain a liquid market.
The landscape today is meaningfully different. The growth of KiwiSaver has built a substantial base of institutional capital with a genuine need for equity risk management tools. Advances in trading technology, greater participation from systematic and algorithmic investors, and a more coordinated approach from market participants all support the conditions needed for this product to succeed.
Benefits for Clients and the Broader Market
For Jarden's clients —including institutional investors, fund managers, corporations and sophisticated private investors — the S&P/NZX 20 Index Futures contract offers a range of practical benefits that have not previously been available through an exchange-traded product in New Zealand:
- Hedging New Zealand equity exposure directly on-exchange, without the need for offshore proxies or over-the-counter instruments
- Capital-efficient access to the New Zealand equity market, enabling investors to adjust their exposure quickly and cost-effectively
- A broader range of investment strategies, including tactical asset allocation, long/short positioning, and basis trading
- Accessibility for a wider investor base, with a contract size of NZ$1 per index point designed to be practical for both institutional and retail participants
Jarden's Listed Derivatives desk will support clients from launch and will provide ongoing assistance to clients looking to incorporate the product into their portfolios or risk management frameworks.
A Positive Step for New Zealand Capital Markets
Beyond the direct benefits to investors, the establishment of a functioning equity derivatives market is expected to contribute to improved liquidity in the secondary market for NZX-listed issuers, greater investment choice — including within KiwiSaver— and a deeper, more mature capital markets ecosystem overall.
Reynolds added: “Jarden has a long history of supporting the development of New Zealand's financial markets, from its participation in the NZX dairy futures market to its foreign exchange, carbon markets and listed derivatives. We look forward to working collaboratively with NZX, fellow participants and clients to help build a sustainable and active market in S&P/NZX 20 Index Futures.”
